Oscar Health (OSCR) Change in Receivables (2020 - 2026)

Oscar Health has reported Change in Receivables for 7 years, with the latest figure at $224.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables rose 129.27% year-over-year to $224.3 million; the trailing twelve-month figure through Mar 2026 stood at $228.4 million (up 219.36% YoY), and the FY2025 full-year result was $101.9 million, down 10.84% from the prior year.
• Change in Receivables for Q1 2026 stood at $224.3 million, up from -$2.9 million in the prior quarter.
• The five-year high for Change in Receivables was $224.3 million in Q1 2026, with the low at -$98.0 million in Q3 2024.
• Historically, Change in Receivables has averaged $31.5 million across 5 years, with a median of $16.5 million in 2024.
• The largest YoY upside for Change in Receivables was 740.74% in 2024 against a maximum downside of 703.68% in 2024.
• Oscar Health's Change in Receivables stood at $4.0 million in 2022, then soared by 170.12% to $10.8 million in 2023, then surged by 52.61% to $16.5 million in 2024, then tumbled by 117.67% to -$2.9 million in 2025, then surged by 7812.79% to $224.3 million in 2026.
• The last three Change in Receivables figures came in at $224.3 million (Q1 2026), -$2.9 million (Q4 2025), and -$20.0 million (Q3 2025), per Business Quant data.